Rapid screening and data to quickly reach your preclinical milestone.
Preformulation screening services to take you through to formulation development
Quotient Sciences’ experienced scientists can support your preformulation screening to allow selection of your drug candidate for preclinical evaluation and identification of your drug product in early clinical evaluation.
Our rapid screening approach uses techniques such as particle size analysis, solubility screening, amorphous content and candidate stability to identify your lead candidates, which can then be developed into formulations for preclinical evaluation as either simple solutions/suspensions or more complex formulations.
Reach your preclinical milestone faster
Leverage our support to rapidly screen excipients and select appropriate formulations so you can begin preclinical studies in a matter of weeks, not months.
We deliver high-quality reports and communication between your team and our expert scientists. You can be assured that the rapid data presented is accurate and interpreted in a timely manner.
